The Department of Epidemiology, the largest department at Pitt Public Health, offers interdisciplinary research opportunities in the City Of Pittsburgh, which is recognized as an international hub for health care innovation and practice. The school is one of the nation’s leading schools of public health, consistently ranking in the top tier among schools of public health in terms of NIH funding. The Department of Epidemiology accounts for about forty percent of the school’s total grant funding.
The Department of Epidemiology has a central theme of "Teaching and Prevention through Quality Research," and is involved in both research and prevention activities. The department’s primary faculty members have a varied range of research interests reflected in more than 90 funded projects and more than 500 publications each year. Faculty, staff and student participation in regular seminars provides a rich collaborative environment.
Based on faculty research, the department offers many areas of emphasis including aging, applied public health, cancer, cardiovascular and diabetes, clinical trials and methods, environmental, global health, infectious disease, injury prevention, molecular and genetics, neuroepidemiology, obesity and nutritional, prevention, lifestyle and physical activity, psychiatric, reproductive, perinatal and pediatric and women’s health epidemiology.
Research programs include those with global reach in over a dozen nations including: maternal and child health (rural India); functional disability in aging (rural India); diabetes (Rwanda), hypertension, cardiovascular disease (rural India, Tobago); impaired kidney function (Tobago); infectious disease/HIV (Brazil, India, and Mozambique); bone health (Tobago); prostate cancer (Tobago, Nigeria); cancer (China); environmental health (China); application of the Internet and Mobile technology for global health and prevention; Infectious diseases/dengue modeling (Thailand, Cambodia, Laos, Vietnam, Philippines, Singapore, Malaysia, Taiwan, Brazil, Columbia); atherosclerosis, coronary heart disease, Alzheimer’s disease, chronic obstructive pulmonary disease (Japan).